Literature DB >> 11147797

Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function.

K Maedler1, G A Spinas, D Dyntar, W Moritz, N Kaiser, M Y Donath.   

Abstract

Glucotoxicity and lipotoxicity contribute to the impaired beta-cell function observed in type 2 diabetes. Here we examine the effect of saturated and unsaturated fatty acids at different glucose concentrations on beta-cell proliferation and apoptosis. Adult rat pancreatic islets were cultured onto plates coated with extracellular matrix derived from bovine corneal endothelial cells. Exposure of islets to saturated fatty acid (0.5 mmol/l palmitic acid) in medium containing 5.5, 11.1, or 33.3 mmol/l glucose for 4 days resulted in a five- to ninefold increase of beta-cell DNA fragmentation. In contrast, monounsaturated palmitoleic acid alone (0.5 mmol/l) or in combination with palmitic acid (0.25 or 0.5 mmol/l each) did not affect DNA fragmentation. Increasing concentrations of glucose promoted beta-cell proliferation that was dramatically reduced by palmitic acid. Palmitoleic acid enhanced the proliferation activity in medium containing 5.5 mmol/l glucose but had no additional effect at higher glucose concentrations (11.1 and 33.3 mmol/l). The cell-permeable ceramide analog C2-ceramide mimicked both the palmitic acid-induced beta-cell apoptosis and decrease in proliferation. Moreover, the ceramide synthetase inhibitor fumonisin B1 blocked the deleterious effects of palmitic acid on beta-cell viability. Additionally, palmitic acid but not palmitoleic acid decreased the expression of the mitochondrial adenine nucleotide translocator and induced release of cytochrome c from the mitochondria into the cytosol. Finally, palmitoleic acid improved beta-cell-secretory function that was reduced by palmitic acid. Taken together, these results suggest that the lipotoxic effect of the saturated palmitic acid involves an increased apoptosis rate coupled with reduced proliferation capacity of beta-cells and impaired insulin secretion. The deleterious effect of palmitate on beta-cell turnover is mediated via formation of ceramide and activation of the apoptotic mitochondrial pathway. In contrast, the monounsaturated palmitoleic acid does not affect beta-cell apoptosis, yet it promotes beta-cell proliferation at low glucose concentrations, counteracting the negative effects of palmitic acid as well as improving beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11147797     DOI: 10.2337/diabetes.50.1.69

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  176 in total

1.  Mapping the triglyceride distribution in NAFLD human liver by MALDI imaging mass spectrometry reveals molecular differences in micro and macro steatosis.

Authors:  Hussam Alamri; Nathan Heath Patterson; Ethan Yang; Pablo Zoroquiain; Anthoula Lazaris; Pierre Chaurand; Peter Metrakos
Journal:  Anal Bioanal Chem       Date:  2018-12-05       Impact factor: 4.142

2.  The p21-activated kinase (PAK1) is involved in diet-induced beta cell mass expansion and survival in mice and human islets.

Authors:  Miwon Ahn; Stephanie M Yoder; Zhanxiang Wang; Eunjin Oh; Latha Ramalingam; Ragadeepthi Tunduguru; Debbie C Thurmond
Journal:  Diabetologia       Date:  2016-07-09       Impact factor: 10.122

3.  Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.

Authors:  Annalisa Natalicchio; Rossella Labarbuta; Federica Tortosa; Giuseppina Biondi; Nicola Marrano; Alessandro Peschechera; Emanuele Carchia; Maura Roberta Orlando; Anna Leonardini; Angelo Cignarelli; Piero Marchetti; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2013-08-31       Impact factor: 10.122

4.  Novel proapoptotic effect of hepatocyte growth factor: synergy with palmitate to cause pancreatic {beta}-cell apoptosis.

Authors:  José A González-Pertusa; John Dubé; Shelley R Valle; Taylor C Rosa; Karen K Takane; José M Mellado-Gil; Germán Perdomo; Rupangi C Vasavada; Adolfo García-Ocaña
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

5.  Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells.

Authors:  Shaobo Zhang; Yanzhu Yang; Yuguang Shi
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

6.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Perilipin is present in islets of Langerhans and protects against lipotoxicity when overexpressed in the beta-cell line INS-1.

Authors:  Jörgen Borg; Cecilia Klint; Nils Wierup; Kristoffer Ström; Sara Larsson; Frank Sundler; Roberto Lupi; Piero Marchetti; Guoheng Xu; Alan Kimmel; Constantine Londos; Cecilia Holm
Journal:  Endocrinology       Date:  2009-03-19       Impact factor: 4.736

8.  Islet beta cell failure in the 60% pancreatectomised obese hyperlipidaemic Zucker fatty rat: severe dysfunction with altered glycerolipid metabolism without steatosis or a falling beta cell mass.

Authors:  V Delghingaro-Augusto; C J Nolan; D Gupta; T L Jetton; M G Latour; M Peshavaria; S R Murthy Madiraju; E Joly; M-L Peyot; M Prentki; J Leahy
Journal:  Diabetologia       Date:  2009-03-18       Impact factor: 10.122

9.  Distinct patterns of fat metabolism in skeletal muscle of normal-weight, overweight, and obese humans.

Authors:  S Sendhil Velan; Nicholas Said; Christopher Durst; Stephanie Frisbee; Jefferson Frisbee; Raymond R Raylman; M Albert Thomas; Vazhaikkurichi M Rajendran; Richard G Spencer; Stephen E Alway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-30       Impact factor: 3.619

10.  Peroxisome proliferator-activated receptor alpha (PPARalpha) protects against oleate-induced INS-1E beta cell dysfunction by preserving carbohydrate metabolism.

Authors:  F Frigerio; T Brun; C Bartley; A Usardi; D Bosco; K Ravnskjaer; S Mandrup; P Maechler
Journal:  Diabetologia       Date:  2009-11-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.